Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Statement concerning the second revision of the British guidelines on asthma management

Statement concerning the second revision of the British guidelines on asthma management Review Statement concerning the second revision of the British guidelines on asthma management P Stephenson, on behalf of the Steering Committee of the General Practitioners in Asthma Group 19,20 INTRODUCTION given by equivalent delivery systems. Low-dose The second revision of the British (also known as the FP is effective and superior to sodium cromoglycate 1 21 BTS) guidelines on asthma management represent a in young children with mild to moderate asthma. consensus statement developed by an expert multidisci- plinary panel, whose judgements were supported by eight – Budesonide (BUD) via a Turbohaler™ 2-9 background review papers. The rationale behind these Therapeutic doses should be halved when changing 10-12 and previous guidelines has been summarised by the delivery of BUD from pressurised metered dose 13 17 Harrison. The GPIAG has been at the forefront of inhaler (pMDI) to a turbulent flow inhaler. changes in primary care management of asthma over the past 10 years and the group has participated in the – Side-effects of inhaled steroids production of all three sets of BTS guidelines. During The side-effect profile for those patients on low to this second revision the GPIAG was represented by six moderate doses of inhaled steroids is extremely http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png npj Primary Care Respiratory Medicine Springer Journals

Statement concerning the second revision of the British guidelines on asthma management

Download PDF
3 pages

Loading next page...
 
/lp/springer-journals/statement-concerning-the-second-revision-of-the-british-guidelines-on-qyCFY9SdPq
Publisher
Springer Journals
Copyright
Copyright © 1997 by General Practice Airways Group (GPIAG)
Subject
Medicine & Public Health; Medicine/Public Health, general; Primary Care Medicine; Internal Medicine; Pneumology/Respiratory System; Thoracic Surgery
eISSN
1475-1534
DOI
10.1038/pcrj.1997.2
Publisher site
See Article on Publisher Site

Abstract

Review Statement concerning the second revision of the British guidelines on asthma management P Stephenson, on behalf of the Steering Committee of the General Practitioners in Asthma Group 19,20 INTRODUCTION given by equivalent delivery systems. Low-dose The second revision of the British (also known as the FP is effective and superior to sodium cromoglycate 1 21 BTS) guidelines on asthma management represent a in young children with mild to moderate asthma. consensus statement developed by an expert multidisci- plinary panel, whose judgements were supported by eight – Budesonide (BUD) via a Turbohaler™ 2-9 background review papers. The rationale behind these Therapeutic doses should be halved when changing 10-12 and previous guidelines has been summarised by the delivery of BUD from pressurised metered dose 13 17 Harrison. The GPIAG has been at the forefront of inhaler (pMDI) to a turbulent flow inhaler. changes in primary care management of asthma over the past 10 years and the group has participated in the – Side-effects of inhaled steroids production of all three sets of BTS guidelines. During The side-effect profile for those patients on low to this second revision the GPIAG was represented by six moderate doses of inhaled steroids is extremely

Journal

npj Primary Care Respiratory Medicine – Springer Journals

Published: Jun 1, 1997

There are no references for this article.